New anxiety treatment enters Mid-Stage testing
NCT ID NCT06051721
Summary
This study is testing an investigational medicine called CYB004 in adults with moderate to severe generalized anxiety disorder (GAD). It aims to see if CYB004 can safely reduce anxiety symptoms in people whose current medications aren't working well enough. The trial will compare CYB004 against an active control treatment in 36 participants to measure changes in anxiety and depression scores.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED ANXIETY DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedar Clinical Research
Murray, Utah, 84107, United States
-
CenExel ACMR
Atlanta, Georgia, 30331, United States
-
Innovative Clinical Research, Inc.
Miami Lakes, Florida, 33016, United States
-
Research Centers of America
Hollywood, Florida, 33024, United States
-
Uptown Research Institute
Chicago, Illinois, 60640, United States
-
iResearch Atlanta
Decatur, Georgia, 30330, United States
Conditions
Explore the condition pages connected to this study.